Pharmaceutical companies brace for Trump tariff details

Drug manufacturers and consumers are waiting anxiously for the White House to release more details on tariffs targeting pharmaceuticals. Last month, Donald Trump's "Liberation Day" announcement slapped a 10 per cent baseline tariff on exports from many countries, including Australia. And while medical devices were included, pharmaceuticals were spared. Guest: Dr John LaMattina, the former Senior Vice President of Pfizer Inc and former President of Pfizer Global Research and Development Producers: Brooke Young and Rob Kelly